{"count": 6, "results": [{"_id": "36689497", "pmid": 36689497, "title": "Association of metformin use and survival in patients with cutaneous melanoma and diabetes.", "journal": "Br J Dermatol", "authors": ["Krakowski I", "Häbel H", "Nielsen K", "Ingvar C", "Andersson TML", "Girnita A", "Smedby KE", "Eriksson H"], "date": "2023-01-23T00:00:00Z", "doi": "10.1093/bjd/ljac003", "meta_date_publication": "2023 Jan 23", "meta_volume": "188", "meta_issue": "1", "meta_pages": "32-40", "score": 50269.023, "text_hl": "Association of @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ use and survival in @SPECIES_9606 @@@patients@@@ with @<m>DISEASE_Melanoma_Cutaneous_Malignant</m> @DISEASE_MESH:C562393 @@@cutaneous melanoma@@@ and @DISEASE_Diabetes_Mellitus @DISEASE_MESH:D003920 @@@diabetes@@@.", "citations": {"NLM": "Krakowski I, Häbel H, Nielsen K, Ingvar C, Andersson TML, Girnita A, Smedby KE, Eriksson H. Association of metformin use and survival in patients with cutaneous melanoma and diabetes. Br J Dermatol. 2023 Jan 23;188(1):32-40. PMID: 36689497", "BibTeX": "@article{36689497, title={Association of metformin use and survival in patients with cutaneous melanoma and diabetes.}, author={Krakowski I and Häbel H and Nielsen K and Ingvar C and Andersson TML and Girnita A and Smedby KE and Eriksson H}, journal={Br J Dermatol}, volume={188}, number={1}, pages={32-40}}"}}, {"_id": "40318300", "pmid": 40318300, "title": "Metformin regulates ferroptosis in Skin cutaneous melanoma via ATF3/NRF2 axis.", "journal": "Cancer Genet", "authors": ["Gu D", "Sun Y", "Wang J", "Sun J", "Lou H", "Kang W"], "date": "2025-04-26T00:00:00Z", "doi": "10.1016/j.cancergen.2025.04.006", "meta_date_publication": "2025 Apr 26", "meta_volume": "294-295", "meta_issue": "", "meta_pages": "136-144", "score": 50265.0, "text_hl": "@<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@Metformin@@@ regulates ferroptosis in @<m>DISEASE_Melanoma_Cutaneous_Malignant</m> @DISEASE_MESH:C562393 @@@Skin cutaneous melanoma@@@ via @GENE_ATF3 @GENE_467 @@@ATF3@@@/@GENE_NFE2L2 @GENE_4780 @@@NRF2@@@ axis.", "citations": {"NLM": "Gu D, Sun Y, Wang J, Sun J, Lou H, Kang W. Metformin regulates ferroptosis in Skin cutaneous melanoma via ATF3/NRF2 axis. Cancer Genet. 2025 Apr 26;294-295():136-144. PMID: 40318300", "BibTeX": "@article{40318300, title={Metformin regulates ferroptosis in Skin cutaneous melanoma via ATF3/NRF2 axis.}, author={Gu D and Sun Y and Wang J and Sun J and Lou H and Kang W}, journal={Cancer Genet}, volume={294-295}, pages={136-144}}"}}, {"_id": "37397389", "pmid": 37397389, "pmcid": "PMC10312386", "title": "Metformin is associated with improved clinical outcomes in patients with melanoma: a retrospective, multi-institutional study", "journal": "Front Oncol", "authors": ["Augustin RC", "Huang Z", "Ding F", "Zhai S", "McArdle J", "Santisi A", "Davis M", "Sander C", "Davar D", "Kirkwood JM", "Delgoffe GM", "Warner AB", "Najjar YG"], "date": "2023-06-16T00:00:00Z", "doi": "10.3389/fonc.2023.1075823", "meta_date_publication": "2023", "meta_volume": "13", "meta_issue": "", "meta_pages": "1075823", "score": 50248.39, "text_hl": "Recurrence rates stratified by stage/subgroup and @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ exposure.", "citations": {"NLM": "Augustin RC, Huang Z, Ding F, Zhai S, McArdle J, Santisi A, Davis M, Sander C, Davar D, Kirkwood JM, Delgoffe GM, Warner AB, Najjar YG. Metformin is associated with improved clinical outcomes in patients with melanoma: a retrospective, multi-institutional study Front Oncol. 2023;13():1075823. PMID: 37397389", "BibTeX": "@article{37397389, title={Metformin is associated with improved clinical outcomes in patients with melanoma: a retrospective, multi-institutional study}, author={Augustin RC and Huang Z and Ding F and Zhai S and McArdle J and Santisi A and Davis M and Sander C and Davar D and Kirkwood JM and Delgoffe GM and Warner AB and Najjar YG}, journal={Front Oncol}, volume={13}, pages={1075823}}"}}, {"_id": "33453061", "pmid": 33453061, "title": "Relationship between type 2 diabetes mellitus and markers of cutaneous melanoma aggressiveness: an observational multicentric study in 443 patients with melanoma.", "journal": "Br J Dermatol", "authors": ["Nagore E", "Martinez-Garcia MA", "Gomez-Olivas JD", "Manrique-Silva E", "Martorell A", "Bañuls J", "Carrera C", "Ortiz P", "Gardeazabal J", "Boada A", "de Eusebio E", "Chiner E", "Gonzalez C", "Pérez-Gil A", "Cullen D", "Formigón M", "de Unamuno B", "Navarro-Soriano C", "Muriel A", "Gozal D"], "date": "2021-10-01T00:00:00Z", "doi": "10.1111/bjd.19813", "meta_date_publication": "2021 Oct", "meta_volume": "185", "meta_issue": "4", "meta_pages": "756-763", "score": 50247.305, "text_hl": "OBJECTIVES: To explore potential associations between @DISEASE_Diabetes_Mellitus_Type_2 @DISEASE_MESH:D003924 @@@T2DM@@@, glycaemic control and @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ treatment and the aggressiveness of @<m>DISEASE_Melanoma_Cutaneous_Malignant</m> @DISEASE_MESH:C562393 @@@cutaneous melanoma@@@. ", "citations": {"NLM": "Nagore E, Martinez-Garcia MA, Gomez-Olivas JD, Manrique-Silva E, Martorell A, Bañuls J, Carrera C, Ortiz P, Gardeazabal J, Boada A, de Eusebio E, Chiner E, Gonzalez C, Pérez-Gil A, Cullen D, Formigón M, de Unamuno B, Navarro-Soriano C, Muriel A, Gozal D. Relationship between type 2 diabetes mellitus and markers of cutaneous melanoma aggressiveness: an observational multicentric study in 443 patients with melanoma. Br J Dermatol. 2021 Oct;185(4):756-763. PMID: 33453061", "BibTeX": "@article{33453061, title={Relationship between type 2 diabetes mellitus and markers of cutaneous melanoma aggressiveness: an observational multicentric study in 443 patients with melanoma.}, author={Nagore E and Martinez-Garcia MA and Gomez-Olivas JD and Manrique-Silva E and Martorell A and Bañuls J and Carrera C and Ortiz P and Gardeazabal J and Boada A and de Eusebio E and Chiner E and Gonzalez C and Pérez-Gil A and Cullen D and Formigón M and de Unamuno B and Navarro-Soriano C and Muriel A and Gozal D}, journal={Br J Dermatol}, volume={185}, number={4}, pages={756-763}}"}}, {"_id": "26997714", "pmid": 26997714, "pmcid": "PMC4778205", "title": "Metformin - For the dermatologist", "journal": "Indian J Pharmacol", "authors": ["Bubna AK"], "date": "2016-01-01T00:00:00Z", "doi": "10.4103/0253-7613.174388", "meta_date_publication": "2016 Jan-Feb", "meta_volume": "48", "meta_issue": "1", "meta_pages": "4-10", "score": 50084.203, "text_hl": "Very recently, systemic usage of @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ for @DISEASE_Psoriasis @DISEASE_MESH:D011565 @@@psoriasis@@@ and @<m>DISEASE_Melanoma_Cutaneous_Malignant</m> @DISEASE_MESH:C562393 @@@cutaneous malignancies@@@ has shown promising results. ", "citations": {"NLM": "Bubna AK. Metformin - For the dermatologist Indian J Pharmacol. 2016 Jan-Feb;48(1):4-10. PMID: 26997714", "BibTeX": "@article{26997714, title={Metformin - For the dermatologist}, author={Bubna AK}, journal={Indian J Pharmacol}, volume={48}, number={1}, pages={4-10}}"}}, {"_id": "30462431", "pmid": 30462431, "title": "[The first results of assessment of clinical efficacy of melatonin and metformin in patients with disseminated skin melanoma receiving dacarbazine as first-line systemic therapy].", "journal": "Vopr Onkol", "authors": ["Novik AV", "Protsenko SA", "Baldueva IA", "Berstein LM", "Anisimov VN", "Semenova AI", "Latipova DK", "Tkachenko EV", "Semiglazova TY"], "date": "2016-01-01T00:00:00Z", "meta_date_publication": "2016", "meta_volume": "62", "meta_issue": "2", "meta_pages": "324-9", "score": 50044.52, "text_hl": "The aim of the study was to assess efficacy and safety of combined therapy with @CHEMICAL_Dacarbazine @CHEMICAL_MESH:D003606 @@@dacarbazine@@@ and @CHEMICAL_Melatonin @CHEMICAL_MESH:D008550 @@@melatonin@@@ or @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ in comparison with @CHEMICAL_Dacarbazine @CHEMICAL_MESH:D003606 @@@dacarbazine@@@ alone in the 1st line of therapy of @<m>DISEASE_Melanoma_Cutaneous_Malignant</m> @DISEASE_MESH:C562393 @@@cutaneous melanoma@@@. ", "citations": {"NLM": "Novik AV, Protsenko SA, Baldueva IA, Berstein LM, Anisimov VN, Semenova AI, Latipova DK, Tkachenko EV, Semiglazova TY. [The first results of assessment of clinical efficacy of melatonin and metformin in patients with disseminated skin melanoma receiving dacarbazine as first-line systemic therapy]. Vopr Onkol. 2016;62(2):324-9. PMID: 30462431", "BibTeX": "@article{30462431, title={[The first results of assessment of clinical efficacy of melatonin and metformin in patients with disseminated skin melanoma receiving dacarbazine as first-line systemic therapy].}, author={Novik AV and Protsenko SA and Baldueva IA and Berstein LM and Anisimov VN and Semenova AI and Latipova DK and Tkachenko EV and Semiglazova TY}, journal={Vopr Onkol}, volume={62}, number={2}, pages={324-9}}"}}]}